Imino sugars are potent agonists of the human glucose sensor SGLT3

Molecular Pharmacology

Volumn 71, Issue 2, 2007, Pages 628-634

  Voss, Andrew A ^a   Díez Sampedro, Ana ^a   Hirayama, Bruce A ^a   Loo, Donald D F ^a   Wright, Ernest M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYGALACTONOJIRIMYCIN; 1 DEOXYNOJIRIMYCIN; 1 DEOXYNOJIRIMYCIN 1 SULFONIC ACID; 1,5 ANHYDROSORBITOL; 4 DEOXY 4 FLUOROGALACTOSE; 4 DEOXY 4 FLUOROGLUCOSE; ALPHA GLUCOSIDASE; ALPHA METHYLGLUCOSE; CARRIER PROTEINS AND BINDING PROTEINS; GALACTOSE; GLUCOSE; IMINOSUGAR; MIGLITOL; MIGLUSTAT; N ETHYL 1 DEOXYNOJIRIMYCIN; PHLORIZIN; SODIUM GLUCOSE COTRANSPORTER 1; SODIUM GLUCOSE COTRANSPORTER 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOSENSOR; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG BINDING; DRUG MECHANISM; DRUG TARGETING; ELECTROPHYSIOLOGY; ENZYME SPECIFICITY; MEMBRANE POTENTIAL; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOPUS LAEVIS;

ANIMALS; BIOSENSING TECHNIQUES; ELECTROPHYSIOLOGY; HUMANS; IMINO SUGARS; OOCYTES; PROTEIN BINDING; SODIUM-GLUCOSE TRANSPORT PROTEINS; SUBSTRATE SPECIFICITY; TRANSFECTION; XENOPUS LAEVIS;

EID: 33846406395     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.030288     Document Type: Article

References (37)

1. Abramson J, Smirnova I, Kasho V, Verner G, Kaback HR, and Iwata S (2003) Structure and mechanism of the lactose permease of Escherichia coli. Science (Wash DC) 301:610-615.
2. Andersson U, Smith D, Jeyakumar M, Butters TD, Borja MC, Dwek RA, and Platt FM (2004) Improved outcome of N-butyldeoxygalactonojirimycin- mediated substrate reduction therapy in a mouse model of Sandhoff disease. Neurobiol Dis 16:506-515.
3. Asano N (2003) Glycosidase inhibitors: update and perspectives on practical use. Glycobiology 13:93R-104R.
4. Biffinger JC, Kim HW, and DiMagno SG (2004) The polar hydrophobicity of fluorinated compounds. Chembiochem 5:622-627.
5. Butters TD, Dwek RA, and Platt FM (2005) Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses. Glycobiology 10:43R-52R.
6. Cox T, Lachmann R, Hollak C, Aerts J, van Weely S, Hrebicek M, Platt F, Butters T, Dwek R, Moyses C, et al. (2000) Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet 355:1481-1485.
7. Diez-Sampedro A, Hirayama BA, Osswald C, Gorboulev V, Baumgarten K, Volk C, Wright EM, and Koepsell H (2003) A glucose sensor hiding in a family of transporters. Proc Natl Acad Sci USA 100:11753-11758.
8. +-dependent glucose cotransporters: comparison of SGLT1 and SGLT3. J Membr Biol 176:111-117.
9. +/glucose cotransporter. J Biol Chem 276:49188-49194.
10. Dunitz JD (2004) Organic fluorine: odd man out. Chembiochem 5:614-621.
11. Elstein D, Hollak C, Aerts JM, van Weely S, Maas M, Cox TM, Lachmann RH, Hrebicek M, Platt FM, Butters TD, et al. (2004) Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease. J Inherit Metab Dis 27:757-766.
12. Freeman SL, Bohan D, Darcel N, and Raybould HE (2006) Luminal glucose sensing in the rat intestine has characteristics of a sodium-glucose cotransporter. Am J Physiol 291:G439-G445.
13. Godin G, Compain P, Martin OR, Ikeda K, Yu L, and Asano N (2004) Alpha-1-C-alkyl-1-deoxynojirimycin derivatives as potent and selective inhibitors of intestinal isomaltase: remarkable effect of the alkyl chain length on glycosidase inhibitory profile. Bioorg Med Chem Lett 14:5991-5995.
14. Gribble FM, Williams L, Simpson AK, and Reimann F (2003) A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52:1147-1154.
15. Harris EMS, Aleshin AE, Firsov LM, and Honzatko RB (1993) Refined structure for the complex of 1-deoxynojirimycin with glucoamylase from Aspergillus awamori var. X100 to 2.4-Å resolution. Biochemistry 32:1618-1626.
16. +/proline cotransporters. Proc Natl Acad Sci USA 86:5748-5752.
17. -/GABA (HGAT1) cotransporters. Br J Pharmacol 134:484-495.
18. Hoffmann M and Rychlewski J (2001) Effects of substituting a OH group by a F atom in D-glucose. Ab initio and DFT analysis. J Am Chem Soc 123:2308-2316.
19. +/glucose cotransporter cloned from rabbit small intestine. J Membr Biol 110:87-95.
20. Kato A, Kato N, Kano E, Adachi I, Ikeda K, Yu L, Okamoto T, Banba Y, Ouchi H, Takahata H, et al. (2005) Biological properties of D- and L-1-deoxyazasugars. J Med Chem 48:2036-2044.
21. Kim M, Cooke HJ, Javed NH, Carey HV, Christofi F, and Raybould HE (2001) D-Glucose releases 5-hydroxytryptamine from human BON cells as a model of enterochromaffin cells. Gastroenterology 121:1400-1406.
22. Klingenberg M (2005) Ligand-protein interaction in biomembrane carriers. The induced transition fit of transport catalysis. Biochemistry 44:8563-8570.
23. +/glucose cotransporter. Proc Natl Acad Sci USA 90:5767-5771.
24. +/glucose cotransporter. J Gen Physiol 125:13-36.
25. +/glucose cotransporter (SGLT1) currents and fluxes. J Membr Biol 162:101-106.
26. +/glucose cotransporter: I. Voltage-clamp studies. J Membr Biol 125:49-62.
27. +/glucose cotransporter: II. A transport model under nonrapid equilibrium conditions. J Membr Biol 125:63-79.
28. Park BK, Kitteringham NR, and O'Neill PM (2001) Metabolism of fluorine-containing drugs. Annu Rev Pharmacol Toxicol 41:443-470.
29. Pastores GM and Barnett NL (2003) Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1. Exp Opin Investig Drugs 12:273-281.
30. Platt FM and Butters TD (2000) Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseases. Expert Rev Mol Med 2000:1-17.
31. Quiocho FA (1989) Protein-carbohydrate interactions - basic molecular-features. Pure Appl Chem 61:1293-1306.
32. Raybould HE, Cooke HJ, and Christofi FL (2004) Sensory mechanisms: transmitters, modulators and reflexes. Neurogastroenterol Motil 16 (Suppl 1):60-63.
33. Taroni C, Jones S, and Thornton JM (2000) Analysis and prediction of carbohydrate binding sites. Protein Eng 13:89-98.
34. van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, and Van Weel C (2005) Alpha-Glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev CD003639.
35. +-glucose cotransporters: SLC5. Physiology (Bethesda) 19:370-376.
36. Wright EM, Loo DD, Hirayama BA, and Turk E (2006) Sugar absorption, in Physiology of the Gastrointestinal Tract (Johnson L, Barrett K, Ghishan F, Merchant J, Said H, and Wood J eds) pp 1653-1665, Elsevier Academic Press, Boston.
37. Wright EM, van Os CH, and Mircheff AK (1980) Sugar uptake by intestinal basolateral membrane vesicles. Biochim Biophys Acta 597:112-124.